Abstract:Abstract Introduction Hematopoietic stem cells (HSCs) sustain lifelong blood production and can be used in allogenic stem cell transplantation for treatment of hematological malignancies, yet the mechanisms of their DNA damage response (DDR) remain largely unexplored. Genotoxic damage can be induced by chemotherapeutical agents (eg, etoposide, a topoisomerase II inhibitor) or by methylating agents (eg, nitrosamines). Related double strand breaks (DSBs) at the level of immature cells are thus presumed to trigger leukemia. Objective Human quiescent and cycling HSCs were reported to exhibit distinct responses to genotoxic stress upon in vitro exposure to sublethal doses of etoposide or N-nitroso-N-methylurea (MNU). In this context, we aim to identify and compare the mechanisms involved in the determination of HSC stem and progenitor cell fate upon DNA damage to gain more insights into cytotoxic anticancer drug- and contaminant-related hematological toxicity. Methods Quiescent human HSCs (CD34+) were isolated from umbilical cord blood, sorted and directly exposed to etoposide or MNU. Besides, CD34+ were expanded in-vitro in medium containing broad acting cytokines for 5 days prior genotoxic exposure. Sublethal doses were assessed by Alamar Blue assay. Propidium iodide staining and colony-forming unit assay (CFU) were used for cell cycle analysis and tracking of cell functionality. Results In vitro inhibitory concentrations were identified for human HSCs treated with etoposide (IC50 = 5 μM) and MNU (IC50 = 1 mM). Treatment of quiescent HSCs with lower genotoxin concentrations induces a cell cycle arrest in the G0/G1-phase, whereas higher concentrations activate apoptosis-related genes and completely abrogate further differentiation into colony-forming progenitors. In contrast, cycling HSCs exhibit an impaired proliferation, upregulation of autophagy-related genes, reduced proportions of viable CD34+ cells, and similar effects regarding differentiation capacity into colony-forming progenitors. However, cells exposed to lower genotoxin doses exhibit a higher regeneration capacity 3 days upon treatment. Discussion These results confirm that the DDR following DSB-induction differs between quiescent and cycling HSCs. Quiescent HSCs exhibit a stronger DDR, probably related to their longer lifespan. To avoid malignant transformation, it is necessary to preclude damage accumulation through cell cycle withdrawal and apoptosis. In contrast, more committed cells rather inline toward damage repair and restoration through activation of, for example, non-homologous end joining or mismatch repair genes.

Proliferative events ameliorate DNA damage accumulation without affecting function in hematopoietic stem cells

DNA methylation drives hematopoietic stem cell aging phenotypes after proliferative stress

Deficiencies in DNA damage repair limit the function of haematopoietic stem cells with age

DNA Damage Response in Quiescent Hematopoietic Stem Cells and Leukemia Stem Cells.

DNA Damage Response in Hematopoietic Stem Cell Ageing

DNA Damage and Repair in the Hematopoietic System

Abstract 1 Distinctive and Differentiation-State Dependent DNA Damage Response of Hematopoietic Stem Cells to Genotoxic Noxae

Clonal hematopoiesis in frequent whole blood donors

Aging alters the cell cycle control and mitogenic signaling responses of human hematopoietic stem cells

3216 – GENOTOXIC FORMALDEHYDE ACCELERATES AGEING IN HEMATOPOIETIC STEM CELLS IN A P53-DRIVEN MANNER

Immunoaging induced by hematopoietic stem cell aging.

Evaluation of DNA Damage and Repair In In Vitro Expanded Cord Blood CD 34 Positive Hematopoietic Stem Cell

An epigenetic component of hematopoietic stem cell aging amenable to reprogramming into a young state

Aging of hematopoietic stem cells: DNA damage and mutations?

Understanding intrinsic hematopoietic stem cell aging

Aged hematopoietic stem cells are refractory to bloodborne systemic rejuvenation interventions

Per2 Induction Limits Lymphoid-Biased Haematopoietic Stem Cells and Lymphopoiesis in the Context of DNA Damage and Ageing

DNA Damage as a Critical Factor of Stem Cell Aging and Organ Homeostasis

Telomere Dysfunction and Cell Cycle Checkpoints in Hematopoietic Stem Cell Aging

Integrated Single-Cell Bioinformatics Analysis Reveals Intrinsic and Extrinsic Biological Characteristics of Hematopoietic Stem Cell Aging

Long‐term mid‐onset dietary restriction rejuvenates hematopoietic stem cells and improves regeneration capacity of total bone marrow from aged mice